Renal dopaminergic system activity in uninephrectomized rats up to 26 weeks after surgery

American Journal of Nephrology

Volumn 27, Issue 3, 2007, Pages 232-239

  Moreira Rodrigues, M ^a   Sampaio Maia, B ^a   Moura, M ^b   Pestana, M ^a,c  

^a Inst of Pharmacol and Therapeutics   (Portugal)

^b Institute of Pharmacology and Therapeutics   (Portugal)

^c University of Porto   (Portugal)

Author keywords

Blood pressure; Dopamine; Kidney; Renal mass reduction

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; SODIUM;

ADAPTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPAMINERGIC SYSTEM; KIDNEY FUNCTION; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; UNINEPHRECTOMY; ANIMAL; KIDNEY; METABOLISM; NEPHRECTOMY; PHYSIOLOGY; URINE; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; DOPAMINE; KIDNEY; MALE; NEPHRECTOMY; RATS; RATS, WISTAR; SODIUM;

EID: 34250796732     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101368     Document Type: Article

References (30)

1. Hayashi M, Yamaji Y, Kitajima W, Saruta T: Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 1990;258:F28-F33.
2. Soares-da-Silva P, Fernandes MH: Regulation of dopamine synthesis in the rat kidney. J Auton Pharmacol 1990;10:s25-s30.
3. Soares-da-Silva P, Fernandes MH, Pinto-do OP: Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br J Pharmacol 1994;112:611-615.
4. Aperia AC: Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 2000;62:621-647.
5. Carey RM: Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure. Hypertension 2001;38:297-302.
6. Hussain T, Lokhandwala MF: Renal dopamine receptor function in hypertension. Hypertension 1998;32:187-197.
7. Jose PA, Raymond JR, Bates MD, Aperia A, Felder RA, Carey RM: The renal dopamine receptors (editorial). J Am Soc Nephrol 1992;2:1265-1278.
8. Carey RM, Siragy HM, Felder RA: Physiological modulation of renal function by the renal dopaminergic system. J Auton Pharmacol 1990;10(suppl 1):s47-s51.
9. Pelayo JC, Fildes RD, Eisner GM, Jose PA: Effects of dopamine blockade on renal sodium excretion. Am J Physiol 1983;245:F247-F253.
10. +exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 1990;259:F297-F303.
11. Gill JR, Jr., Gullner G, Lake CR, Lakatua DJ, Lan G: Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988;11:312-319.
12. Jose PA, Eisner GM, Felder RA: Renal dopamine receptors in health and hypertension. Pharmacol Ther 1998;80:149-182.
13. Hayslett JP: Functional adaptation to reduction in renal mass. Physiol Rev 1979;59:137-164.
14. Sampaio-Maia B, Serrao P, Guimaraes JT, Vieira-Coelho MA, Pestana M: Renal dopaminergic system activity in the rat remnant kidney. Nephron Exp Nephrol 2005;99:e46-e55.
15. Vieira-Coelho MA, Serrao P, Guimaraes JT, Pestana M, Soares-da-Silva P: Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney. Am J Physiol 2000;279:F1033-F1044.
16. Soares-Da-Silva P, Serrao MP, Vieira-Coelho MA: Apical and basolateral uptake and intracellular fate of dopamine precursor L-Dopa in LLC-PK1 cells. Am J Physiol 1998;274:F243-F251.
17. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-254.
18. Pestana M, Vieira-Coelho MA, Pinto-do OP, Fernandes MH, Soares-da-Silva P: Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat. Br J Pharmacol 1995;115:1349-1358.
19. Vieira-Coelho MA, Hussain T, Kansra V, Serrao MP, Guimaraes JT, Pestana M, Soares-Da-Silva P, Lokhandwala MF: Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats. Hypertension 1999;34:666-672.
20. Motulsky H, Spannard P, Neubig R: Graph Pad Prism. San Diego, Graph Pad Prism Software, 1994.
21. Davis CL, Delmonico FL: Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005;16:2098-2110.
22. Mimran A, Mourad G, Ribstein J: Early systemic and renal responses to nephrectomy in normotensive kidney donors. Nephrol Dial Transplant 1993;8:448-453.
23. Kasiske BL, Ma JZ, Louis TA, Swan SK: Long-term effects of reduced renal mass in humans. Kidney Int 1995;48:814-819.
24. Miller IJ, Suthanthiran M, Riggio RR, Williams JJ, Riehle RA, Vaughan ED, Stubenbord WT, Mouradian J, Cheigh JS, Stenzel KH: Impact of renal donation. Long-term clinical and biochemical follow-up of living donors in a single center. Am J Med 1985;79:201-208.
25. Isaac J, Berndt TJ, Thothathri V, Tyce GM, Knox FG: Catecholamines and phosphate excretion by the remnant kidney. Kidney Int 1993;43:1021-1026.
26. Jose PA, Eisner GM, Felder RA: Dopamine receptor-coupling defect in hypertension. Curr Hypertens Rep 2002;4:237-244.
27. Pestana M, Jardim H, Correia F, Vieira-Coelho MA, Soares-da-Silva P: Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension. Nephrol Dial Transplant 2001;16:53-59.
28. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM: Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 1989;257:F469-F477.
29. Anderson WP, Evans RG, Malpas SC: Pressure natriuresis and long-term blood pressure control. J Cardiovasc Pharmacol 1995;26(suppl 2):S17-S23.
30. Preston RA, Epstein M: Renal parenchymal disease and hypertension. Semin Nephrol 1995;15:138-151.